Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Maltais, S. Singh, A. Donald, A. Church, G. Crater, A. Goh, J. Riley (Québec, Mississauga, Canada; Leicester, Uxbridge, United Kingdom; Research Triangle Park, United States Of America). Effects of a combination of vilanterol and umeclidinium on exercise endurance in subjects with COPD: Two randomised clinical trials. Eur Respir J 2013; 42: Suppl. 57, 761

Member's Comments

No comment yet.

Related content which might interest you: Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study Source: ERJ Open Res, 4 (1) 00073-2017; 10.1183/23120541.00073-2017 Year: 2018 A systematic review and meta-analysis of the effect of dual versus mono- long-acting bronchodilator therapy on exercise endurance in COPD Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases Year: 2016 A randomised double-blind placebo-controlled trial of the effect of inhaled heparin on lung function, hyperinflation and exercise capacity in patients with COPD Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial Source: Eur Respir J, 50 (4) 1701235; 10.1183/13993003.01235-2017 Year: 2017 QVA149 is more efficacious than tiotropium and salmeterol/fluticasone combination (SFC) in improving patient-reported outcomes and lung function in COPD patients with moderate-to-severe baseline dyspnoea: The IGNITE trials Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Effect of hyperoxia on exercise performance in COPD: Randomized trial Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease Year: 2016 Effects of 12 weeks of once-daily tiotropium and olodaterol fixed-dose combination on exercise endurance in patients with COPD Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015 Effects of high-repetitive single limb exercises (HRSLE) on functional exercise capacity in patients with COPD – Randomized controlled multicenter trial Source: Annual Congress 2013 –Rehabilitation, exercise and adjunct physiotherapy techniques in different respiratory conditions Year: 2013 Late-breaking abstract: Once-daily NVA237 improves exercise endurance from first dose in patients with COPD: The GLOW3 trial Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease Year: 2011 INSTEAD: Randomized switch trial of indacaterol and salmeterol/fluticasone combination (SFC) in moderate COPD: Symptoms results Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Effect of inhaled vaporized cannabis on dynamic airway function, breathlessness and exercise intolerance in adults with advanced COPD: A randomized controlled trial Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function Year: 2018 Exercise and cardiovascular benefit in subjects with COPD: the need for randomised trials Source: Eur Respir J 2014; 44: 263-264 Year: 2014 Exercise and cardiovascular benefit in subjects with COPD: the need for randomised trials Source: Eur Respir J 2014; 44: 264-265 Year: 2014 Effect of 8 and 12 weeks’ once-daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with COPD Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 QVA149 reduces the risk of moderate-to-severe exacerbations compared with open-label tiotropium in patients with severe COPD: The SPARK study Source: International Congress 2014 – Asthma and COPD management Year: 2014 Efficacy of tiotropium and indacaterol alone or the combination on dynamic lung hyperinflation and exercise tolerance in COPD Source: International Congress 2014 – Asthma and COPD management Year: 2014 Once-daily QVA149 demonstrates superior improvements in patient-reported dyspnea compared to tiotropium in patients with moderate-to-severe COPD: The BLAZE study Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Effects of a training program including downhill walking in COPD: A randomized controlled trial Source: International Congress 2016 – Best abstracts on the role of exercise and physical activity in chronic respiratory disease Year: 2016